Back to trial details

Intake questionnaire

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Applying to Stanford Children's Health · Palo Alto, California

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 2 and 17 years old?
2. Have you been diagnosed with Ulcerative Colitis?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Palo Alto for study visits?